INTRODUCTION ;

Medical electrical devices are evolving rapidly with advanced software, cloud connectivity, and network integration. While these innovations improve clinical outcomes, they also introduce new cybersecurity attack surfaces that can directly affect patient safety and essential performance. Under IEC 60601, cybersecurity vulnerabilities are now treated as potential safety hazards that must be identified, assessed, and controlled.

In Finland’s advanced and innovation-driven healthcare ecosystem, regulators and conformity assessment bodies increasingly expect Vulnerability Assessment and Penetration Testing (VA/PT) as part of cybersecurity assurance. Cyberintelsys delivers IEC 60601-aligned VA/PT services, using CREST-recognized testing methodologies, to help medical device manufacturers achieve secure and compliant products.

Cybersecurity and Safety Convergence in

IEC 60601

IEC 60601 focuses on ensuring that medical electrical equipment does not pose unacceptable risks to patients, operators, or the clinical environment. Today, cybersecurity failures such as unauthorized access, data manipulation, or system disruption can compromise:

• Essential performance

• Therapy accuracy and device outputs

• Alarm functionality and monitoring systems

• Availability of critical medical devices

As a result, cybersecurity testing is now an essential component of overall device safety assurance.

Why Vulnerability Assessment & Penetration Testing Is Essential

VA/PT provides practical, real-world evidence that a medical device can withstand cybersecurity threats without impacting safety or performance. For IEC 60601 compliance, VA/PT helps manufacturers:

• Identify exploitable vulnerabilities before regulatory testing

• Validate the effectiveness of implemented security controls

• Reduce the risk of non-conformities during conformity assessment

• Strengthen confidence with regulators and healthcare providers

In Finland, VA/PT is increasingly viewed as a best practice for cybersecurity readiness.

Cyberintelsys IEC 60601 VA/PT Methodology

1. Medical Device Attack Surface Analysis

Cyberintelsys begins by analyzing the complete attack surface, including:

• Network and wireless communication interfaces

• Embedded software and firmware components

• User authentication and access mechanisms

• Data storage and transmission pathways

• Third-party libraries and external dependencies

This ensures no critical exposure points are overlooked.

2. Structured Vulnerability Assessment

The vulnerability assessment phase includes:

• Secure configuration and architecture review

• Identification of known and emerging vulnerabilities

• Evaluation of encryption, authentication, and access control

• Assessment of software update and patching mechanisms

Findings are mapped to IEC 60601 safety impacts and ISO 14971 risk criteria.

3. CREST-Aligned Penetration Testing

Cyberintelsys performs CREST-aligned penetration testing designed specifically for medical devices, ensuring:

• Controlled testing that does not disrupt essential performance

• Simulation of realistic attacker behavior

• Verification of defense-in-depth controls

• Clear evidence suitable for regulatory review

Testing is carefully planned to maintain patient and operator safety.

4. Risk Evaluation and Remediation Support

All identified vulnerabilities are:

• Categorized by severity and exploitability

• Linked to potential safety consequences

• Prioritized for remediation

• Re-tested to confirm effectiveness

Cyberintelsys supports manufacturers in implementing risk-appropriate security controls.

Alignment with IEC, ISO, and Lifecycle Security Standards

Cyberintelsys aligns VA/PT outcomes with:

• IEC 60601 – Safety and essential performance

• ISO 14971 – Medical device risk management

• IEC 81001-5-1 – Secure product lifecycle processes

• CREST methodologies – Trusted penetration testing practices

This integrated approach ensures cybersecurity testing supports both technical security and regulatory compliance.

Cybersecurity Evidence for Compliance and Market Readiness

Regulators and test laboratories expect clear, traceable evidence. Cyberintelsys provides:

• VA/PT reports tailored for medical device compliance

• Threat-to-risk-to-control traceability

• Residual risk justification

• Inputs for the Risk Management File and technical documentation

These deliverables strengthen IEC 60601 conformity assessments and broader regulatory submissions.

Supporting Finland’s Advanced MedTech Landscape

Finland is a leader in digital health and medical innovation. Proactive VA/PT helps manufacturers:

• Protect patient safety in connected environments

• Reduce costly redesigns and testing delays

• Improve long-term device resilience

• Enhance trust with healthcare providers and regulators

Cybersecurity readiness is now a key indicator of medical device quality and reliability.

Why Choose Cyberintelsys

• Deep expertise in medical device cybersecurity

• Strong alignment with IEC, ISO, and CREST frameworks

• Safe, controlled testing tailored for medical devices

• Clear, regulator-ready reporting

• Support for Finnish, EU, and global compliance pathways

Cyberintelsys helps manufacturers move from vulnerability discovery to compliance confidence.

Conclusion

IEC 60601 vulnerability assessment and penetration testing are critical for ensuring that medical electrical devices remain safe, secure, and fit for modern healthcare environments. By combining CREST-aligned VA/PT, ISO-based risk management, and deep understanding of medical device safety requirements, Cyberintelsys enables manufacturers in Finland to demonstrate robust cybersecurity readiness.

A proactive, standards-driven VA/PT strategy not only supports successful conformity assessments but also strengthens patient safety, protects essential performance, and ensures long-term regulatory trust.